IMM-H014;quantitative proton nuclear magnetic resonance;methodology validation;purity;metabolic-associated fatty liver disease Graphical Abstract 1. Introduction Metabolic-associated fatty liver disease (MAFLD), which used to be called non-alcoholic fatty lipid disease, is a hepatic manifestation of a meta...
An accurate, rapid, and selective quantitative nuclear magnetic resonance method was developed and validated to assess the purity of IMM-H014, a novel drug for the treatment of metabolic-associated fatty liver disease (MAFLD), and four related substances (impurities I, II, III, and IV). In ...